Cargando…
Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design
Various bacterial species cycle between growth phases and biofilm formation, of which the latter facilitates persistence in inhospitable environments. These phases can be generally characterized by one or more cellular phenotype(s), each with distinct virulence factor functionality. In addition, a v...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073711/ https://www.ncbi.nlm.nih.gov/pubmed/29949876 http://dx.doi.org/10.3390/ma11071086 |
_version_ | 1783344250174308352 |
---|---|
author | Beitelshees, Marie Hill, Andrew Jones, Charles H. Pfeifer, Blaine A. |
author_facet | Beitelshees, Marie Hill, Andrew Jones, Charles H. Pfeifer, Blaine A. |
author_sort | Beitelshees, Marie |
collection | PubMed |
description | Various bacterial species cycle between growth phases and biofilm formation, of which the latter facilitates persistence in inhospitable environments. These phases can be generally characterized by one or more cellular phenotype(s), each with distinct virulence factor functionality. In addition, a variety of phenotypes can often be observed within the phases themselves, which can be dependent on host conditions or the presence of nutrient and oxygen gradients within the biofilm itself (i.e., microenvironments). Currently, most anti-biofilm strategies have targeted a single phenotype; this approach has driven effective, yet incomplete, protection due to the lack of consideration of gene expression dynamics throughout the bacteria’s pathogenesis. As such, this article provides an overview of the distinct phenotypes found within each biofilm development phase and demonstrates the unique anti-biofilm solutions each phase offers. However, we conclude that a combinatorial approach must be taken to provide complete protection against biofilm forming bacterial and their resulting diseases. |
format | Online Article Text |
id | pubmed-6073711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60737112018-08-13 Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design Beitelshees, Marie Hill, Andrew Jones, Charles H. Pfeifer, Blaine A. Materials (Basel) Review Various bacterial species cycle between growth phases and biofilm formation, of which the latter facilitates persistence in inhospitable environments. These phases can be generally characterized by one or more cellular phenotype(s), each with distinct virulence factor functionality. In addition, a variety of phenotypes can often be observed within the phases themselves, which can be dependent on host conditions or the presence of nutrient and oxygen gradients within the biofilm itself (i.e., microenvironments). Currently, most anti-biofilm strategies have targeted a single phenotype; this approach has driven effective, yet incomplete, protection due to the lack of consideration of gene expression dynamics throughout the bacteria’s pathogenesis. As such, this article provides an overview of the distinct phenotypes found within each biofilm development phase and demonstrates the unique anti-biofilm solutions each phase offers. However, we conclude that a combinatorial approach must be taken to provide complete protection against biofilm forming bacterial and their resulting diseases. MDPI 2018-06-26 /pmc/articles/PMC6073711/ /pubmed/29949876 http://dx.doi.org/10.3390/ma11071086 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Beitelshees, Marie Hill, Andrew Jones, Charles H. Pfeifer, Blaine A. Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design |
title | Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design |
title_full | Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design |
title_fullStr | Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design |
title_full_unstemmed | Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design |
title_short | Phenotypic Variation during Biofilm Formation: Implications for Anti-Biofilm Therapeutic Design |
title_sort | phenotypic variation during biofilm formation: implications for anti-biofilm therapeutic design |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073711/ https://www.ncbi.nlm.nih.gov/pubmed/29949876 http://dx.doi.org/10.3390/ma11071086 |
work_keys_str_mv | AT beitelsheesmarie phenotypicvariationduringbiofilmformationimplicationsforantibiofilmtherapeuticdesign AT hillandrew phenotypicvariationduringbiofilmformationimplicationsforantibiofilmtherapeuticdesign AT jonescharlesh phenotypicvariationduringbiofilmformationimplicationsforantibiofilmtherapeuticdesign AT pfeiferblainea phenotypicvariationduringbiofilmformationimplicationsforantibiofilmtherapeuticdesign |